Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

OI | Vol. 37, No. 1, 2022 | accc-cancer.org 1 compliance 2022 Oncology Coding Update BY TERI BEDARD, BA, RT(R)(T), CPC • C56.3: Malignant neoplasm of bilateral ovaries • C79.63: Secondary malignant neoplasm of bilateral ovaries. There are also new codes related to anaplas- tic large cell lymphoma for breast cancer. Added codes and guidance include the following: • C84.79A: Anaplastic …
In 2020, medical experts warned that COVID-19 could, over time, have a substantial impact on cancer outcomes due to delayed or missed cancer screenings for patients. To obtain a better perspective of how cancer programs’ screening and outreach education efforts are recovering from pandemic pressures, ACCCBuzz spoke to four cancer programs across the country.
ASSESS & IMPROVE HEALTH LITERACY AT YOUR CANCER PROGRAM HEALTH LITERACY: FROM ASSESSMENT TO ACTION ASSOCIATION OF COMMUNITY CANCER CENTERS ii ASSOCIATION OF COMMUNITY CANCER CENTERS | accc-cancer.org ©2018. Copyright Association of Community Cancer Centers. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means …
1 The Association of Community Cancer Centers (ACCC) education program, Preparing Community Providers for Bispecific Antibodies, seeks to identify and address barriers to the awareness, prepared- ness, adoption, and use of bispecific antibodies (BsAbs) for the treatment of cancer by the cancer care team. This publication provides an overview of bispecific antibodies and presents the results …
ACCC 48TH ANNUAL MEETING & CANCER CENTER BUSINESS SUMMIT March 2–4, 2022 Washington Hilton, DC For details on speakers, sessions, and registration rates, visit ACCC-CANCER.ORG/AMCCBS CO-HOSTS ACCC Continues to Monitor COVID-19 The Association of Community Cancer Centers (ACCC) would like to reaffirm its commitment to the health and safety of our guests and the patients that you serve. Current …
OVERCOMING PROSTATE CANCER DISPARITIES IN CARE ASSOCIATION OF COMMUNITY CANCER CENTERS TABLE OF CONTENTS Introduction 2 Disparities in Care 2 PSA Testing 2 Practice Profiles 3 ChristianaCare’s Helen F. Graham Cancer Center & Research Institute 4 Spencer Cancer Center of East Alabama Health 7 The Ohio State University Comprehensive Cancer Center …
January 11, 2022
Addressing disparities in prostate cancer requires the ability to recognize that care inequities exist and to commit to proven efforts to provide equitable care to all patients. This is not an easy undertaking—but an essential one for any healthcare team.
To obtain an on-the-ground perspective of how cancer programs’ screening and outreach education efforts are reacting to pandemic pressures, ACCCBuzz spoke to four cancer programs across the country that will be featured in four separate blog posts in January 2022. For the first blog in the series, we spoke to Renea Duffin, MPA, vice president of cancer support and outreach at Mary Bird Perkins Cancer …
ACCC—along with five cancer advocacy organizations—urged Congress to pass and President Biden to sign the bipartisan Medicare Multi-Cancer Early Detection Screening Coverage Act (S.1873/H.R.1946) to increase early-stage diagnosis and enable earlier treatment for a wider range of cancers. Read Letter
ACCC_MBC_OI.indd In 2021, ACCC held a series of focus groups to learn how cancer programs are effectively implementing telehealth to man- age symptoms and treatment side effects, deliver psychosocial screening and support services, and provide genetic counseling and testing. Practical tips from these focus groups include: • Orient patients, caregivers, and care partners to the …
1 Successful Delivery of Services Through Telehealth: A Focus on Symptom Management, Psychological Health, and Genetic Counseling in Metastatic Breast Cancer In 2019, the Association of Community Cancer Centers (ACCC) held a Multidisciplinary Metastatic Breast Cancer (MBC) Summit focused on addressing disparities in care for patients with metastatic breast cancer. Leveraging …
ACORI Call to Action Summit Executive Summary ACCC COMMUNITY ONCOLOGY RESEARCH INSTITUTE Contents Summit Overview ........................................................................................................................... 2 ACORI Call to Action Summit Agenda ........................................................................................... 2 …
Genetic counselors can help individuals understand their risk of cancer, make medical decisions based on relevant genetic findings, take steps to lower their cancer risk, and make informed decisions about the most effective course of treatment after a cancer diagnosis. But despite the importance of the services they provide, genetic counselors are not considered to be providers, and their services …
ACCC stands with its members and the entire oncology community in prioritizing equity, diversity, and inclusion in quality cancer care delivery and within the oncology workforce.
We support all healthcare and long-term care employers requiring their workers to be vaccinated against COVID-19.
Wednesday, March 2 3:00 – 4:00 PM EST Re-Thinking Cancer Survivorship Barbara McAneny, MD, MACP, FASCO, Chief Executive Officer, New Mexico Cancer Center, Oncology Hematology Consultants @BarbaraMcAneny Kimberly Peairs, MD, Vice Chair for Ambulatory Operations, Department of Medicine; Associate Professor of Medicine, The Johns Hopkins Hospital, The Sidney Kimmel Comprehensive …
Given the difficulty of managing patients with a high disease burden who are often undergoing toxic treatment regimens and managing multiple office visits, maintaining high-quality ovarian cancer care can be a challenge.
Given the difficulty of managing patients with a high disease burden who are often undergoing toxic treatment regimens and managing multiple office visits, maintaining high-quality ovarian cancer care can be a challenge.
December 16, 2021
Bispecific antibodies are an emerging class of novel immunotherapy agents that have led to major breakthroughs in treating hematologic malignancies—and have promising applications for solid tumors.